2seventy bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	56.79	74.96	71.03	130.41	0	0
Short-Term Investments	124.59	142.03	195.24	134.64	0	0
Cash & Cash Equivalents	181.38	216.99	266.27	265.06	0	0
Cash Growth	-46.64%	-18.51%	0.46%	-	-	-
Receivables	11.98	13.41	20.96	17	10.69	7.43
Other Current Assets	19.48	7.37	13.65	9.51	14.41	13.42
Total Current Assets	212.84	237.77	300.88	291.56	25.1	20.84
Property, Plant & Equipment	253.55	278.11	296.62	310.45	260.48	257.52
Long-Term Investments	38.24	42.96	39.81	97.12	0	0
Goodwill and Intangibles	6.42	6.59	19.36	21.95	18.77	22.53
Other Long-Term Assets	0	0	0	38.59	8.26	14.05
Total Long-Term Assets	298.21	327.66	355.78	468.11	287.52	294.11
Total Assets	511.05	565.43	656.67	759.68	312.62	314.95
Accounts Payable	8.8	6.03	7.21	6.02	7.15	20.39
Deferred Revenue	18.79	19.32	8	30.76	26.58	18.27
Current Debt	13.01	12.66	11.16	9.77	15.31	11.32
Other Current Liabilities	19.81	21.77	53.42	51.83	26.82	53.43
Total Current Liabilities	60.41	59.78	79.79	98.39	75.87	103.4
Long-Term Debt	240.07	244.01	259.01	272.45	112.29	122.26
Other Long-Term Liabilities	3.14	6.33	7.4	29.02	49.83	45.6
Total Long-Term Liabilities	243.21	250.35	266.41	301.47	162.12	167.86
Total Liabilities	303.61	310.13	346.2	399.85	237.99	271.26
Total Debt	253.08	256.67	270.17	282.22	127.6	133.58
Debt Growth	-5.20%	-5.00%	-4.27%	121.17%	-4.47%	-
Retained Earnings	-563.89	-511.22	-293.65	-39.49	0	-
Comprehensive Income	-0.34	-0.2	-2.88	-0.71	0	0
Shareholders' Equity	207.44	255.3	310.47	359.82	74.63	43.69
Net Cash / Debt	-71.7	-39.68	-3.9	-17.16	-127.6	-133.58
Net Cash Per Share	-1.38	-0.81	-0.11	-0.73	-5.46	-5.72
Working Capital	152.44	177.99	221.09	193.18	-50.76	-82.56
Book Value Per Share	3.98	5.18	8.71	15.31	3.19	1.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).